The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause
Nom du journal : Breast Cancer Res Treat
Année : 2012
Volume : 131
Page de départ : 295
Page de fin : 306